Susan Hasty, Publisher
Table of Contents . . . June 3rd, 1996Non-Subscriber - Summaries Only
Conference Coverage (ASM) - Cytokine Enhanced Sub-Unit TB Vaccine Feasible
Conference Coverage (ASM) - Modified SDA Effectively Detects TB
Conference Coverage (ASM) - TB Cultures May Be Unnecessary in Some Groups
Healthcare Issues - Drug Companies' Control of Pharmaceutical Benefits: Conflict of Interest?
Animal Models - Philippine Cynomolgus Monkey Superior for Study of TB
Bacterial Vaccines - Safe Vaccine Against Gram-Negative Bacteria Nears Clinical Trials
Disease Progression - Paradoxical Worsening of TB Effusions Not Uncommon
Drug Susceptibility - HPA Fast and Reliable for Drug Susceptibility Testing
International (North and South America) - Spread of Infectious Diseases Continues
TB Vaccines - Vaccine Doesn't Produce Deceptive Positive Skin Tests
TB/HIV Coinfection - Isoniazid Resistant TB Not Higher in HIV Positive Individuals
Therapy - Surgical Management of TB Still Critical
Disease Identification - "Genetic Characterization of an Unidentified Mycobacterium."
Therapy (Antimycobacterial) - "Intracellular Activity of Imipenem against Mycobacterium tuberculosis and M. avium."
Vaccine Development (Mycobacteria) - "Development of New Apramycin Resistant Vectors for Gene Transfer in Mycobacteria."
Vaccine Development (Mycobacterial) - "Construction of an Efficient Shuttle Phagemid Vector and Expression of a Recombinant 21k M. Paratuberculosis Antigen in M. Smegmatis."
Infection Control - "Tuberculosis Control in Health Care Workers: An Algorithmic Approach."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.